List of Tables
Table 1 North America Cancer Diagnostics Market Size, By Value (USD Million), 2019-2030
Table 2 North America Cancer Diagnostics Market Share, By Products, By Value (USD Million), 2019-2030
Table 3 North America Cancer Diagnostics Market Share, By Test Type, By Value (USD Million), 2019-2030
Table 4 North America Cancer Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
Table 5 North America Cancer Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
Table 6 North America Cancer Diagnostics Market Share, By Country, By Value (USD Million), 2019-2030
Table 7 United States Cancer Diagnostics Market Size, By Value (USD Million), 2019-2030
Table 8 United States Cancer Diagnostics Market Share, By Products, By Value (USD Million), 2019-2030
Table 9 United States Cancer Diagnostics Market Share, By Test Type, By Value (USD Million), 2019-2030
Table 10 United States Cancer Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
Table 11 United States Cancer Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
Table 12 Canada Cancer Diagnostics Market Size, By Value (USD Million), 2019-2030
Table 13 Canada Cancer Diagnostics Market Share, By Products, By Value (USD Million), 2019-2030
Table 14 Canada Cancer Diagnostics Market Share, By Test Type, By Value (USD Million), 2019-2030
Table 15 Canada Cancer Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
Table 16 Canada Cancer Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
Table 18 Roche Diagnostics Company Overview
Table 19 Roche Diagnostics Financial Overview
Table 20 Cancer Diagnostics, Inc. Company Overview
Table 21 Cancer Diagnostics, Inc. Financial Overview
Table 22 Agilent Technologies Company Overview
Table 23 Agilent Technologies Financial Overview
Table 24 BD Company Overview
Table 25 BD Financial Overview
Table 26 Telix Pharmaceuticals Limited Company Overview
Table 27 Telix Pharmaceuticals Limited Financial Overview
Table 28 Abbott Company Overview
Table 29 Abbott Financial Overview
Table 30 NeoGenomics Laboratories, Inc Company Overview
Table 31 NeoGenomics Laboratories, Inc Financial Overview
Table 32 Telerad Tech Company Overview
Table 33 Telerad Tech Financial Overview
Table 34 The Menarini Group Company Overview
Table 35 The Menarini Group Financial Overview
Table 36 Hologic, Inc Company Overview
Table 37 Hologic, Inc Financial Overview
Table 38 Illumina, Inc. Company Overview
Table 39 Illumina, Inc. Financial Overview
Table 40 Thermo Fisher Scientific Inc., Company Overview
Table 41 Thermo Fisher Scientific Inc., Financial Overview
Table 42 QIAGEN Company Overview
Table 43 QIAGEN Financial Overview
Table 44 Epredia Company Overview
Table 45 Epredia Financial Overview
LIST OF FIGURE
Figures
Figure 1 North America Cancer Diagnostics Segmentation
Figure 2 North America Cancer Diagnostics Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 North America Cancer Diagnostics Market Size, By Value (USD Million), 2019-2030
Figure 5 North America Cancer Diagnostics Market Share, By Products, By Value (USD Million), 2019-2030
Figure 6 North America Cancer Diagnostics Market Share, By Test Type, By Value (USD Million), 2019-2030
Figure 7 North America Cancer Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
Figure 8 North America Cancer Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
Figure 9 North America Cancer Diagnostics Market Share, By Country, By Value (USD Million), 2019-2030
Figure 10 United States Cancer Diagnostics Market Size, By Value (USD Million), 2019-2030
Figure 11 United States Cancer Diagnostics Market Share, By Products, By Value (USD Million), 2019-2030
Figure 12 United States Cancer Diagnostics Market Share, By Test Type, By Value (USD Million), 2019-2030
Figure 13 United States Cancer Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
Figure 14 United States Cancer Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
Figure 15 Canada Cancer Diagnostics Market Size, By Value (USD Million), 2019-2030
Figure 16 Canada Cancer Diagnostics Market Share, By Products, By Value (USD Million), 2019-2030
Figure 17 Canada Cancer Diagnostics Market Share, By Test Type, By Value (USD Million), 2019-2030
Figure 18 Canada Cancer Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
Figure 19 Canada Cancer Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
